WAT$389.69
Chart
Performance
Key Stats
AI WAT Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyWaters Corporation (WAT) presents a balanced investment profile. It exhibits strong fundamental health with consistent profitability and a solid balance sheet, supported by its leadership in analytical workflows. Thematic tailwinds in healthcare and life sciences are positive. However, recent performance indicates a downward trend, and current technical indicators suggest a degree of caution is warranted for short-term trading. A long-term perspective with a focus on its market position and innovation is recommended.
Thematic
Waters Corporation is well-positioned to benefit from key secular growth trends in healthcare, diagnostics, and scientific research. Its advanced analytical workflow solutions are critical for drug discovery, clinical testing, and ensuring quality and safety across various industries.
Fundamental
Waters Corporation demonstrates strong financial health characterized by healthy profitability, a strong balance sheet, and consistent earnings generation, although recent performance metrics show some softening.
Technical
Waters Corporation's stock is currently trading below its key moving averages, indicating a bearish short-term trend. While some oscillators suggest potential for a bounce, the overall technical picture points to a period of consolidation or further downside pressure in the immediate term.
| Factor | Score |
|---|---|
| Healthcare & Life Sciences Demand | 90 |
| Technological Advancements (e.g., AI in R&D) | 80 |
| Quality Control & Safety Standards | 85 |
| Emerging Markets Growth | 85 |
| Competition & Disruption | 70 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 90 |
| Growth | 40 |
| Balance Sheet Health | 75 |
| Cash Flow | 85 |
| Earnings Quality | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 40 |
| Volume Confirmation | 70 |
| Support & Resistance | 60 |
| Short-Term Oscillators | 50 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Consistent EPS Beats
Waters Corporation (WAT) has a history of beating earnings per share (EPS) estimates, with positive surprises in the last 8 reported quarters, averaging a surprise of 4.21%.
Reasonable P/E Ratio
The trailing P/E ratio of 27.11 is below the technology sector average of 30.5, suggesting the stock may be attractively valued relative to its peers.
Bearish Points (7)
Recent Underperformance
The stock has experienced a significant decline over the past month (-15.9%) and 6 months (-27.98%), suggesting potential headwinds or a loss of investor confidence.
High Price-to-Sales Ratio
The trailing Price-to-Sales (P/S) ratio of 7.8 is significantly higher than the industry average of 5.0, indicating that the stock might be overvalued relative to its sales.
Calendar
November 1996
26
Ex-Dividend Date
August 2025
4
Next Earnings Date
H: $3.10
A: $2.95
L: $2.89
H: 770.00M
A: 748.32M
L: 740.00M
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Seasonals
Price Target
373.24 USD
The 39 analysts offering 1 year price forecasts for WAT have a max estimate of 465.00 and a min estimate of 330.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
Primary global competitor in analytical instruments, lab equipment, and life science services, with significant overlap in product offerings and target markets.
Weight: 97
Direct and significant competitor specializing in chromatography, mass spectrometry, spectroscopy, and other analytical instrumentation, serving similar industries.
Weight: 90
Diversified science and technology company with a substantial life sciences segment (e.g., Beckman Coulter, Pall), often competing or collaborating within the broader lab ecosystem.
Weight: 88
Specializes in precision instruments for lab and industrial applications, including analytical instruments, making it a direct peer in the laboratory equipment market.